Accurate IOL power challenging in refractive patients

Article

Achieving the proper IOL power for patients who have had a refractive procedure such as LASIK, PRK, or RK can be challenging, and taking more measurements leads to greater accuracy.

Achieving the proper IOL power for patients who have had a refractive procedure such as LASIK, PRK, or RK can be challenging, and taking more measurements leads to greater accuracy, said Jack T. Holladay, MD, MSEE, FACS, Holladay LASIK Institute and Baylor College of Medicine, Houston, US.

“If we’re going to promise our patients who get a multifocal lens that they’re not going to need to wear glasses, or that they’re not going to need to wear glasses for distance if they get a monofocal lens, there are a number of parameters that we’re going to have to get right,” he said.

“The trouble with arriving at the effective lens position is that we can’t measure it preoperatively because the patient still has a cataract, and we can’t choose it like we do the postoperative refraction,” Dr Holladay said. “So we have to predict [the] value.”

The first “must” in that prediction is accurate biometry, Dr Holladay said. The standard today has become optical coherence tomography, he said, adding, however, that ultrasonic measurements still are required in about 10–15% of cases because of the presence of a dense cataract.

Axial length also is an extremely important consideration, as is anterior segment size, Dr Holladay said. The two are not the same, he emphasized, and an accurate eye model must include nine types of eyes: small, normal, and large anterior segment sizes in eyes with short (<21 mm), normal, and long (>27 mm) axial lengths.

“For example, we find that 80% of short axial lengths (down to 15 mm), have a horizontal white-to-white measurement that’s normal. In other words, the anterior segment of a very short eye is almost independent of the axial length,” Dr Holliday said. “And when you take long eyes, out to 35 mm, you find that these long eyes still have 90% normal white-to-white [measurement].”

He added that, in treating patients who have undergone LASIK or PRK, ophthalmologists trying to arrive at the proper IOL power can “tighten the boundaries” slightly because the corneas in these patients are not as multifocal.

“RK patients, on the other hand, depending on how many incisions were made, how big the optical zone is, and so forth, have a lot more variability, so it's a lot harder to get the exact target,” Dr Holladay said.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.